Kinfo
Ocean Biomedical Inc. logo

Ocean Biomedical Inc.

OCEANASDAQHealthcare·US · USD
$0.00
-0.00 (-37.50%)
Prices as of October 8, 2026 · market closed

Price

Key statistics

Valuation
Market cap185.89K USD
Enterprise value0.00 USD
Trailing P/E-0.00
Forward P/E-0.00
PEG ratio0.00
Price / sales0.00
Price / book-0.00
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-114.87%
Return on equity9.71%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-30.72M USD
Diluted EPS-$0.90
Rev. growth (YoY)0.00%
Balance sheet
Total cash0.00 USD
Total debt15.35M USD
Debt / equity-0.17
Current ratio0.06
Book value / share-$0.56
Cash flow (TTM)
Operating cash flow-4.05M USD
Levered free cash flow-5.34M USD
Shares & price
Shares outstanding166.01M
Float208.41M
Held by institutions0.00%
Beta0.38
50-day MA$0.00
200-day MA$0.00
52-week high$0.01
52-week low$0.00
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-06-030.870.91+4.60%2026-03-20-0.18-0.15+16.67%2026-01-170.380.34−10.53%2024-04-15-0.15-0.52−246.67%2023-08-14-0.19-0.41−115.79%
About Ocean Biomedical Inc.

Ocean Biomedical Inc. is a life sciences company that focuses on developing and commercializing innovative therapeutics. The company's primary function is to bridge the gap between cutting-edge research and the practical treatment of diseases, particularly those with significant unmet medical needs. Ocean Biomedical collaborates with leading research universities and medical institutions to harness their groundbreaking discoveries for clinical applications. By doing so, they target multiple sectors within the biomedical field, including oncology, infectious diseases, and other critical therapeutic areas. The company plays a significant role in the healthcare market by potentially transforming promising scientific breakthroughs into viable medical treatments, thereby facilitating advancements in patient care and health outcomes globally. Ocean Biomedical Inc.'s work contributes to the dynamic and rapidly evolving landscape of medical science, continually pushing the boundaries of what is possible in the fight against complex diseases.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. M. Michelle Berrey M.D., M.P.H.
Employees
7
Headquarters
Providence, RI, United States

Frequently asked questions about Ocean Biomedical Inc.